预防血液透析导管功能障碍的策略
本文综述了血液透析中心静脉导管(CVC)功能障碍的预防策略。血栓形成和纤维鞘形成是置入一周后CVC功能障碍的最常见机制,女性、左侧置管和既往功能障碍是危险因素。每周溶栓封管可改善血流、预防感染并减少需拔管的障碍,但低感染率单位常规使用可能不具成本效益;4%枸橼酸盐封管在预防血栓方面不劣于标准肝素封管,且出血风险可能更低。对称尖端隧道式CVC较阶梯尖端者功能障碍风险更低,多层面CVC护理干预可较常规护理降低功能障碍发生率33%。
要点
- 血栓和纤维鞘是置入一周后CVC功能障碍的最常见机制。
- 每周溶栓封管可改善血流、预防感染并减少需拔管的障碍。
- 4%枸橼酸盐封管预防血栓不劣于标准肝素,出血风险可能更低。
核心结论
- 多层面CVC护理干预可较常规护理降低功能障碍CVC发生率33%。
- 对称尖端隧道式CVC较阶梯尖端者CVC功能障碍风险更低。
研究设计与样本
- 本文为综述,汇总血液透析CVC功能障碍的预防策略。
主要发现
- 血栓形成和纤维鞘形成是置入一周后CVC功能障碍的最常见机制。
- 女性、左侧CVC置管和既往CVC功能障碍与更高的功能障碍风险相关。
- 每周溶栓封管可改善CVC血流速率、预防感染并减少需拔管的功能障碍。
- 浓缩肝素封管(如5000 vs 1000国际单位/ml)与更低治疗性CVC溶栓需求相关,但全身出血风险和成本更高。
- 4%枸橼酸盐封管预防血栓不劣于标准肝素封管,可能出血更少,在某些国家成本更低。
关键数值与推荐
- CVC功能障碍导致高达20%的CVC被拔除。
- 多层面CVC护理干预可较常规护理降低功能障碍CVC发生率33%。
- 浓缩肝素封管比较为5000 vs 1000国际单位/ml。
- 4%枸橼酸盐封管预防血栓不劣于标准肝素封管。
临床怎么用
- 对CVC功能障碍高风险患者(如女性、左侧置管、既往功能障碍)可考虑个体化预防策略。
- 每周溶栓封管在低感染率透析单位常规使用可能不具成本效益。
- 对称尖端隧道式CVC可能降低功能障碍风险。
- 多层面CVC护理干预可降低功能障碍CVC发生率。
局限性
- 在已确立CVC功能障碍患者中靶向使用溶栓封管尚未被研究。
- 常规溶栓封管在低感染率透析单位的成本效益可能有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Millions of patients with kidney failure rely on hemodialysis central venous catheters (CVCs) for their life-sustaining dialysis treatments. CVC dysfunction necessitates removal of up to 20% of CVCs and is an important problem for patients with kidney failure. Thrombosis and fibrin sheath formation are the most common mechanisms of CVC dysfunction beyond the first week after insertion. Factors such as female sex, left-sided CVC placement, and prior CVC dysfunction are associated with a higher risk of dysfunction. Patient-specific factors contribute substantially to variation in the number of CVC dysfunction events. Weekly thrombolytic locks have been shown to improve CVC blood flow rates, prevent infection, and reduce dysfunction requiring removal. However, routine administration may not be cost-effective in hemodialysis units with low infection rates, and targeted use among patients with established CVC dysfunction has not been studied. Concentrated heparin lock ( e.g ., 5000 versus 1000 international unit/ml) has been associated with lower requirements for therapeutic CVC thrombolysis but greater systemic bleeding risks and costs. Citrate 4% was noninferior to standard heparin locks to prevent thrombosis, may cause less bleeding, and is less costly in some countries. Tunneled CVCs with a symmetrical tip have been associated with a lower risk of CVC dysfunction compared with those with a step tip. Multifaceted CVC care interventions can reduce the incidence of dysfunctional CVCs by 33% compared with usual care. Future research to identify patients at high risk of CVC dysfunction will inform individualized vascular access plans, targeted use of preventive strategies, and enrollment criteria for future clinical trials.
引用
- Lazarus B, Lok CE, Moist L, et al. Strategies to Prevent Hemodialysis Catheter Dysfunction. J Am Soc Nephrol. 2025. PMID: 39977120. doi:10.1681/ASN.0000000666
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。